Literature DB >> 2431834

Ultralow doses of vasopressin in the management of diabetes insipidus.

P Chanson, C P Jedynak, G Dabrowski, J E Rohan, A Bouchama, P de Rohan-Chabot, P Loirat.   

Abstract

Management of postoperative diabetes insipidus (DI) frequently requires intermittent treatment with multiple subcutaneous injections of pituitrin or vasopressin, in doses averaging 20 IU/24 h. Use of a syringe pump for a continuous infusion of ultralow doses of pituitrin produced uniform, constant, and sustained reduction of urinary output, thus facilitating regular fluid replacement. Twelve patients with postoperative DI received iv pituitrin at a dose of 1.6 +/- 0.26 mIU/kg X h (1 to 2 IU/24 h). The antidiuretic effect began at the third hour of treatment, peaked by the sixth hour (diuresis of 37 ml/h, specific gravity of 1.018 +/- 0.002), and was sustained throughout infusion. Polyuria recurred 3 h after the infusion was discontinued; this rapid reversibility is highly advantageous when excessive fluid intake causes overhydration. Pressor effects were not observed during the treatment period.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2431834     DOI: 10.1097/00003246-198701000-00010

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

Review 1.  Care of the multiple organ donor.

Authors:  A Bodenham; G R Park
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

2.  CENTRAL DIABETES INSIPIDUS AND CHEMOTHERAPY: USE OF A CONTINUOUS ARGININE VASOPRESSIN INFUSION FOR FLUID AND SODIUM BALANCE.

Authors:  Joshua A Levine; Susan L Karam; Clare O'Connor; Smita Kumar; Malini Soundarrajan; Deepika McConnell; Abeer T Ammar; Ashley M Gale; Donald Zimmerman; Emily D Szmuilowicz
Journal:  AACE Clin Case Rep       Date:  2018 Nov-Dec

3.  Organ retrieval and banking in brain dead trauma patients: Our experience at level-1 trauma centre and current views.

Authors:  Chhavi Sawhney; Manpreet Kaur; Sanjeev Lalwani; Babita Gupta; Ira Balakrishnan; Aarti Vij
Journal:  Indian J Anaesth       Date:  2013-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.